Stem cell startup Aldagen raising $10 million, refiles plans for IPO
It is focused on adult stem cells. Backed by regional venture capital firms Intersouth Partners, Aurora Funds and Trelys Funds along with Harbert Venture Partners and Tullis Dickerson, Aldagen closed on $18.4 million in venture financing in April of …
[Read the full article here]Related News:
Stem cell startup Aldagen earns CEO Cancer ‘Gold Standard’
Stem cell therapy firm Aldagen withdraws plans for
Stem Cell Therapeutics Corp. Announces the Extension of the Expiring Date for $7.7 Million Dollars of Outstanding …